Editorial

From the desk of the editor

Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.

read more
open full screen

Columns

Recent Comments

Click here to read...

Past Editions

Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1

i2P Archives

Health Politics

EPublications

Click here for a list of epublications

ASMI Media Releases August 2010

• Printer-friendly version
• Send to friend
• PDF version
• Share

	Bob Bowden articles by this author...
Information and news from the Australian Self Medication Industry provided by Bob Bowden, Foresight Communications. Contact him on (02) 9241 2811 or 0412 753 298.

About ASMI: The Australian Self-Medication Industry (ASMI) is the peak industry body for the Australian self care industry representing consumer healthcare products including over-the-counter medicines and complementary medicines. ASMI’s mission is to promote better health through responsible self-care. This means ensuring that safe and effective self-care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy. www.asmi.com.au

open this article full screen

3 August 2010

 Calcium supplements and cardiovascular events

The Australian Self Medication Industry (ASMI), the industry body representing non-prescription consumer healthcare products said today that consumers should not be alarmed by recent media coverage linking calcium supplements with an increased risk of heart disease and should seek advice from their healthcare professional if they are concerned about their use of these products.

ASMI was responding to media coverage regarding the safety of calcium supplements following the publication of a recent article by Bolland et al in the British Medical Journal ^[1]. The article by Bolland suggested that the role of calcium supplements should be reassessed because they could increase a person’s risks of heart disease.

ASMI Regulatory and Scientific Affairs Director, Steven Scarff said that there was good evidence that calcium supplements reduced the risk of fractures and hence played a useful role in the treatment of osteoporosis ^{[2, 3]}, and that the association with heart disease was controversial ^[4].

Mr Scarff also said that, in contrast to the Bolland study, other recent studies had failed to find a relationship between calcium supplements and increased cardiovascular risk ^{[5, 6, 7]} or had in fact ruled out such a relationship ^[8].

Mr Scarff said that consumers should continue to aim for the recommended daily calcium intake of 1000-1300mg/day (depending on their age and sex ^[9]) and that they should do this through eating a healthy diet or from supplements where their dietary intake was inadequate.

References

[1] Bolland MJ, Avenell A, Baron JA, Grey A, Maclennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010 Jul 29;341:c3691. doi: 10.1136/bmj.c3691.

[2] Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007 Aug 25;370(9588):657-66.

[3] Osteoporosis Australia web-site. Calcium Supplements and heart Disease. www.osteoporosis.org.au

[4] Gustavo Duque, Jacqueline J Close, Julien P de Jager, Peter R Ebeling, Charles Inderjeeth, Stephen Lord, Andrew J McLachlan, Ian R Reid, Bruce R Troen and Philip N Sambrook. Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention. MJA 2010; 193 (3): 173-179

[5] Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA. Vitamin D and calcium: a systematic review of health outcomes, Evid Rep Technol Assess (Full Rep). 2009 Aug;(183):1-420. Review.

[6] Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010 Mar 2;152(5):315-23. Review.

[7] Sabbagh Z, Vatanparast H. Is calcium supplementation a risk factor for cardiovascular diseases in older women? Nutr Rev. 2009 Feb;67(2):105-8.

[8] Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2010 Jul 7. [Epub ahead of print]

[9] Australian Government, DOHA, NHMRC Recommended Dietary Intakes

Clinical Newsfeed

Click here to read more...

Research Reports

Practice Development

Information Technology

Indigenous Health

Preventive Medicine

i2P Alliance Partners